glp 1 agonist saxenda Order Pens (Liraglutide) from Canada Saxenda (Liraglutide) | Lifestyle Medical

Researchers found that GLP-1 signaling directly correlated with the decrease of pro-inflammatory cytokine production, which includes tumor necrosis factor-alpha (TNF-) and interleukin-6 (IL-6)

Emerging Benefits for Other Conditions The therapeutic potential of GLP-1s continues to expand as research uncovers new applications

[DOI] [PubMed] [Google Scholar] 73.McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, et al

However, the ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) trial found that the once-daily GLP-1 receptor agonist lixisenatide had a neutral effect on cardiovascular outcomes, neither increasing nor decreasing incidence relative to placebo (31)

Instead, Jill was encouraged to aim for 91 grams of protein and up to 30 grams of carbs a day

Newer research indicates they may also be a tool for lowering the risk of heart disease, heart problems, and stroke in patients who are overweight or obese